AQXP - Aquinox Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue25,000---
Cost of Revenue----
Gross Profit25,000---
Operating Expenses
Research Development32,78936,26728,38215,799
Selling General and Administrative14,73514,8529,2635,541
Non Recurring----
Total Operating Expenses47,52451,11937,64521,340
Operating Income or Loss-22,524-51,119-37,645-21,340
Income from Continuing Operations
Total Other Income/Expenses Net-9,061936643-520
Earnings Before Interest and Taxes-22,524-51,119-37,645-21,340
Interest Expense-4-4-1-1
Income Before Tax-31,585-50,183-37,002-21,860
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-31,585-50,183-37,002-21,860
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-31,585-50,183-37,002-21,860
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-31,585-50,183-37,002-21,860